H Verhagen

Author PubWeight™ 42.77‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Epidemiological studies on brassica vegetables and cancer risk. Cancer Epidemiol Biomarkers Prev 1996 2.58
2 A review of mechanisms underlying anticarcinogenicity by brassica vegetables. Chem Biol Interact 1997 1.73
3 Plasma insulin responses after ingestion of different amino acid or protein mixtures with carbohydrate. Am J Clin Nutr 2000 1.72
4 [The prevalence of the metabolic syndrome in the Netherlands: increased risk of cardiovascular diseases and diabetes mellitus type 2 in one quarter of persons under 60]. Ned Tijdschr Geneeskd 2007 1.54
5 Use of dietary supplements in the European Prospective Investigation into Cancer and Nutrition calibration study. Eur J Clin Nutr 2009 1.49
6 Brassica vegetables and cancer prevention. Epidemiology and mechanisms. Adv Exp Med Biol 1999 1.30
7 Intake of butylated hydroxyanisole and butylated hydroxytoluene and stomach cancer risk: results from analyses in the Netherlands Cohort Study. Food Chem Toxicol 2000 1.21
8 Fruits and vegetables increase plasma carotenoids and vitamins and decrease homocysteine in humans. J Nutr 2000 1.09
9 Ingestion of protein hydrolysate and amino acid-carbohydrate mixtures increases postexercise plasma insulin responses in men. J Nutr 2000 1.09
10 State of the art in benefit-risk analysis: environmental health. Food Chem Toxicol 2011 1.08
11 Salinomycin-induced polyneuropathy in cats: morphologic and epidemiologic data. Vet Pathol 1999 1.05
12 Mediterranean diet of Crete: foods and nutrient content. J Am Diet Assoc 2000 1.04
13 Risk-benefit analysis of micronutrients. Food Chem Toxicol 2004 1.00
14 Consumption of Brussels sprouts results in elevated alpha-class glutathione S-transferase levels in human blood plasma. Carcinogenesis 1994 0.94
15 Consuming a diet complying with front-of-pack label criteria may reduce cholesterol levels: a modeling study. Eur J Clin Nutr 2011 0.92
16 Effects of consumption of Brussels sprouts on intestinal and lymphocytic glutathione S-transferases in humans. Carcinogenesis 1995 0.90
17 State of the art in benefit-risk analysis: food and nutrition. Food Chem Toxicol 2011 0.89
18 Dietary intakes of retinol, beta-carotene, vitamin D and vitamin E in the European Prospective Investigation into Cancer and Nutrition cohort. Eur J Clin Nutr 2009 0.87
19 Antimutagenic activity of green tea and black tea extracts studied in a dynamic in vitro gastrointestinal model. Mutat Res 2001 0.86
20 State of the art in benefit-risk analysis: consumer perception. Food Chem Toxicol 2011 0.85
21 Application of a dynamic in vitro gastrointestinal tract model to study the availability of food mutagens, using heterocyclic aromatic amines as model compounds. Food Chem Toxicol 2000 0.85
22 Biomarkers in disease and health. Br J Nutr 2001 0.85
23 Effects of acute (-)-hydroxycitrate supplementation on substrate metabolism at rest and during exercise in humans. Am J Clin Nutr 2000 0.85
24 Effects of consumption of brussels sprouts on plasma and urinary glutathione S-transferase class-alpha and -pi in humans. Carcinogenesis 1995 0.82
25 Dietary intake of the water-soluble vitamins B1, B2, B6, B12 and C in 10 countries in the European Prospective Investigation into Cancer and Nutrition. Eur J Clin Nutr 2009 0.82
26 Biological effects of short-term feeding to rats of repeatedly used deep-frying fats in relation to fat mutagen content. Food Chem Toxicol 1991 0.80
27 The role of biotransformation in dietary (anti)carcinogenesis. Mutat Res 1999 0.80
28 Kinetics of biomarkers: biological and technical validity of isoprostanes in plasma. Amino Acids 2005 0.80
29 In vitro and in vivo inhibition of human flavin-containing monooxygenase form 3 (FMO3) in the presence of dietary indoles. Biochem Pharmacol 1999 0.80
30 Looking beyond borders: integrating best practices in benefit-risk analysis into the field of food and nutrition. Food Chem Toxicol 2011 0.80
31 Markers for cytogenetic damage in smokers: associations with plasma antioxidants and glutathione S-transferase mu. Cancer Epidemiol Biomarkers Prev 1993 0.79
32 The glutathione conjugates of tert-butyl hydroquinone as potent redox cycling agents and possible reactive agents underlying the toxicity of butylated hydroxyanisole. Biochem Biophys Res Commun 1992 0.79
33 Butylated hydroxyanisole, butylated hydroxytoluene and tert.-butylhydroquinone are not mutagenic in the Salmonella/microsome assay using new tester strains. Mutat Res 1988 0.79
34 Safety evaluation of lipase derived from Rhizopus oryzae: summary of toxicological data. Food Chem Toxicol 1997 0.79
35 State of the art in benefit-risk analysis: medicines. Food Chem Toxicol 2011 0.78
36 Effect of eugenol on the genotoxicity of established mutagens in the liver. Food Chem Toxicol 1996 0.78
37 Effect of eugenol on the mutagenicity of benzo[a]pyrene and the formation of benzo[a]pyrene-DNA adducts in the lambda-lacZ-transgenic mouse. Mutat Res 1996 0.78
38 State of the art in benefit-risk analysis: food microbiology. Food Chem Toxicol 2011 0.77
39 Short-term moderate energy restriction does not affect indicators of oxidative stress and genotoxicity in humans. J Nutr 1995 0.76
40 A critical assessment of some biomarker approaches linked with dietary intake. Br J Nutr 2001 0.76
41 Phytosterol consumption and the anabolic steroid boldenone in humans: a hypothesis piloted. Food Addit Contam 2007 0.76
42 Effect of short-term dietary administration of eugenol in humans. Hum Exp Toxicol 1996 0.76
43 Effects of the naturally occurring alkenylbenzenes eugenol and trans-anethole on drug-metabolizing enzymes in the rat liver. Food Chem Toxicol 1993 0.76
44 Antioxidant status in long-term adherents to a strict uncooked vegan diet. Am J Clin Nutr 1995 0.76
45 Safety evaluation of beta-glucanase derived from Trichoderma reesei: summary of toxicological data. Food Chem Toxicol 1995 0.76
46 Do dietary phytochemicals with cytochrome P-450 enzyme-inducing activity increase high-density-lipoprotein concentrations in humans? Am J Clin Nutr 1996 0.75
47 No influence of beta carotene on oxidative DNA damage in male smokers. J Natl Cancer Inst 1995 0.75
48 Biliary excretion of butylated hydroxyanisole in the rat. Food Chem Toxicol 1989 0.75
49 Impact of dietary factors on cancer causes and DNA integrity: new trends and aspects. Food Chem Toxicol 2002 0.75
50 Do we need long-term follow-up after EVAR and TEVAR or can we simplify surveillance protocols? J Cardiovasc Surg (Torino) 2014 0.75
51 Stabilization and quantitative analysis of fecapentaenes in human feces, using synthetic fecapentaene-12. Cancer Lett 1989 0.75
52 Oxidative DNA damage in humans: comparison between high and low habitual fruit and vegetable consumption. Biomarkers 1997 0.75
53 State of the art in benefit-risk analysis: economics and marketing-finance. Food Chem Toxicol 2011 0.75
54 Differentiation of keratinocytes in vitro: a new culture vessel mimicking the in vivo situation. Mol Biol Rep 1985 0.75
55 Biomarkers in nutritional assessment. Bibl Nutr Dieta 1994 0.75
56 Intervention for type II endoleaks? "Primum non nocere": appraisal for the conservative management of low-pressure endoleaks after endovascular aneurysm repair. J Cardiovasc Surg (Torino) 2013 0.75
57 Extra-anatomical reconstruction in the case of an inaccessible groin: the axillopopliteal bypass. Ann Vasc Surg 2007 0.75
58 Inhibition of rat, mouse, and human glutathione S-transferase by eugenol and its oxidation products. Chem Biol Interact 1996 0.75
59 Endoluminal repair of a complex tortuous descending thoracic aortic aneurysm. Eur J Vasc Endovasc Surg 2003 0.75
60 Modulation by dietary factors of BHA-induced alterations in cell kinetics of gastro-intestinal tract tissues in rats. Food Chem Toxicol 1991 0.75
61 Sensitive high-performance liquid chromatographic method for the routine determination of butylated hydroxyanisole in plasma. J Chromatogr 1987 0.75
62 Differentiation of human scalp hair follicle keratinocytes in culture. Virchows Arch B Cell Pathol Incl Mol Pathol 1984 0.75
63 Psoriatic hair-follicle cells. II. Morphological differentiation of outer root-sheath cells in culture. Differentiation 1985 0.75
64 Determination of the gamma-ray dose in an epithermal neutron beam. Strahlenther Onkol 1993 0.75
65 [Observations on oral antidiabetics]. Ned Tijdschr Geneeskd 1966 0.75
66 Antimutagenicity of eugenol in the rodent bone marrow micronucleus test. Mutat Res 1995 0.75